

Fundamental dimension Equity attribute | DIBSLeader $4.53▲+3.90% Cap $152.3MP/E -20.7x QuantScore49/100 | AKAPeer $10.55▲+3.94% Cap $116.0MP/E -4.2x QuantScore35/100 | BARKPeer $7.68▼-0.90% Cap $69.38MP/E -2.1x QuantScore44/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
55/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 37/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 61/100 | 10/100 | 37/100 |
Growth Revenue / earnings growth & margins | 37/100 | 23/100 | 17/100 |
Sentiment Analyst ratings, targets & revisions | 75/100 | 50/100 | 88/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -20.7x | -4.2x | -2.1x |
Forward P/E (next FY) | -26.6x | -6.2x | -5.6x |
EV / EBITDA (TTM) | -40.1x | 95.3x | -4.1x |
Price / Sales | 1.7x | 0.2x | 0.2x |
Price / Free Cash Flow | -102.6x | 12.8x | -2.9x |
PEG ratio | -0.19 | 1.05 | 0.13 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 4 / 9 | 4 / 9 |
Altman Z-Score | -0.75 (Distress) | 0.47 (Distress) | -0.97 (Distress) |
Total debt / equity | 0.22 | 2.26 | 0.48 |
Quick ratio | 3.4x | 0.4x | 0.8x |
Interest coverage | — | -1.6x | -27.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +1.5% | +4.4% | -18.5% |
Net income growth YoY | +26.7% | -20.9% | -18.6% |
Gross margin (TTM) | 74.1% | 59.6% | 63.4% |
Operating margin (FY) | -20.3% | -1.1% | -10.2% |
FCF margin (FY) | -3.6% | -0.1% | -6.7% |
5. Trailing price performancePrice change over period |
1M return | +11.9% | -3.5% | -5.2% |
3M return | +10.2% | -3.8% | -9.8% |
6M return | -16.9% | -5.4% | -19.7% |
Year to date | -24.4% | -1.4% | -36.3% |
1Y return | +38.5% | -27.2% | -55.5% |
3Y return | +18.0% | +55.6% | -63.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.8545 -118.9% premium | $-119.31 -1230.9% premium | $-33.03 -530.1% premium |
Wall Street consensus target | $7.50 +65.6% · range $7.00–$8.00 | $17.50 +65.9% · range $10.00–$25.00 | $15.50 +101.8% · range $12.00–$19.00 |
Consensus stance | 60% Buy40% Hold0% Sell | 18% Buy82% Hold-0% Sell | 75% Buy25% Hold0% Sell |